Refractory Endometrial Endometrioid Adenocarcinoma
2 clinical trials · Condition
◉ Watch Refractory Endometrial Endometrioid Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer (NCT04719273) | Thomas Jefferson University | 2021-01-28 |
| A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma (NCT03008408) | M.D. Anderson Cancer Center | 2017-08-18 |
Track Refractory Endometrial Endometrioid Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.